We generate patient-specific hiPSCs to capture genetic backgrounds and uncover the molecular mechanisms of inherited cardiac diseases. 

Our platform identifies novel cardio-active compounds and tests safety pharmacology to predict cardiotoxicity early in drug development. 

We engineer advanced multicellular 3D constructs that mimic the complex physiology and dynamic function of the native human heart.